|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Total cash and cash equivalents | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Total accounts receivable, net | |||||||||||||||||||
| Inventory, net | |||||||||||||||||||
| Total inventory, net | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property, plant and equipment, net | |||||||||||||||||||
| Total property, plant and equipment, net | |||||||||||||||||||
| Surgical instruments, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Total goodwill | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Other assets, net | |||||||||||||||||||
| Total other assets, net | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Current maturities under capital lease obligation | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Total accounts payable | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Total accrued expenses | |||||||||||||||||||
| Accrued payroll liabilities | |||||||||||||||||||
| Total accrued payroll liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Bank line of credit | |||||||||||||||||||
| Convertible senior notes | |||||||||||||||||||
| Capital lease obligation, net of current maturities | |||||||||||||||||||
| Deferred income taxes, net | |||||||||||||||||||
| Total deferred income taxes, net | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total other liabilities | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||||
| Common stock, $0.001 par value, 750,000,000 shares authorized; 43,774,023 and 43,389,576 shares issued and 43,734,131 and 43,373,611 shares outstanding, respectively | |||||||||||||||||||
| Total common stock, $0.001 par value, 750,000,000 shares authorized; 43,774,023 and 43,389,576 shares issued and 43,734,131 and 43,373,611 shares outstanding, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Total additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||||||||
| Total accumulated other comprehensive (loss) income | |||||||||||||||||||
| Treasury stock, at cost, 39,892 and 15,965 shares, respectively | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
Loading...
